Related Experiment Video
Updated: Mar 16, 2026

Establishment of Orthotopic Patient-derived Xenograft Models for Brain Tumors using a Stereotaxic Device
Published on: May 2, 2025
Health disparities and impact on outcomes in children with primary central nervous system solid tumors
Mary T Austin1,2,3, Emma Hamilton3, Denna Zebda3
1Department of Pediatrics, Children's Cancer Hospital at The University of Texas MD Anderson Cancer Center;
Insights
Racial and ethnic disparities impact pediatric patients with central nervous system (CNS) solid tumors, leading to advanced-stage disease at diagnosis. Survival rates are significantly worse for Hispanic and Black children and those from lower socioeconomic backgrounds.
Area of Science:
- Pediatric Oncology
- Health Disparities Research
- Neuro-oncology
Background:
- Health disparities are well-documented in adult cancer care, affecting access, early detection, and survival.
- Limited research exists on how these disparities influence pediatric malignancies, particularly central nervous system (CNS) solid tumors.
Purpose of the Study:
- To investigate the impact of racial/ethnic and socioeconomic factors on disease presentation and outcomes in pediatric CNS solid tumors.
- To analyze the association between geographic distance to treatment centers and disease stage or survival.
Main Methods:
- Analysis of 2421 pediatric patients (≤18 years) diagnosed with primary CNS solid tumors between 1995-2009 from the Texas Cancer Registry.
- Utilized geocoded data for driving distance to treatment centers and US Census data for socioeconomic status (SES) determination.
- Employed logistic regression for disease stage analysis and Cox regression for survival probability and hazard ratios.
Main Results:
- Children with advanced-stage CNS tumors were more likely to be under 1 year old, Hispanic, or in the lowest SES quartile.
- Hispanic children had higher odds of presenting with advanced-stage disease compared to non-Hispanic white children (OR 1.56).
- Survival probabilities were poorest for children aged 1-10 years, Hispanic patients, non-Hispanic black patients, and those in the lowest SES quartile.
Conclusions:
- Racial and ethnic disparities are linked to advanced-stage disease presentation in pediatric CNS solid tumors.
- Tumor behavior and disease stage at diagnosis are critical predictors of survival in this population.
- Distance to care and SES did not significantly impact disease stage in adjusted analyses, but influenced survival outcomes.
Abstract:
OBJECTIVE Health disparities in access to care, early detection, and survival exist among adult patients with cancer. However, there have been few reports assessing how health disparities impact pediatric patients with malignancies. The objective in this study was to examine the impact of racial/ethnic and social factors on disease presentation and outcome for children with primary CNS solid tumors. METHODS The authors examined all children (age ≤ 18 years) in whom CNS solid tumors were diagnosed and who were enrolled in the Texas Cancer Registry between 1995 and 2009 (n = 2421). Geocoded information was used to calculate the driving distance between a patient's home and the nearest pediatric cancer treatment center. Socioeconomic status (SES) was determined using the Agency for Healthcare Research and Quality formula and 2007-2011 US Census block group data. Logistic regression was used to determine factors associated with advanced-stage disease. Survival probability and hazard ratios were calculated using life table methods and Cox regression. RESULTS Children with advanced-stage CNS solid tumors were more likely to be < 1 year old, Hispanic, and in the lowest SES quartile (all p < 0.05). The adjusted odds ratios of presenting with advanced-stage disease were higher in children < 1 year old compared with children > 10 years old (OR 1.71, 95% CI 1.06-2.75), and in Hispanic patients compared with non-Hispanic white patients (OR 1.56, 95% CI 1.19-2.04). Distance to treatment and SES did not impact disease stage at presentation in the adjusted analysis. Furthermore, 1- and 5-year survival probability were worst in children 1-10 years old, Hispanic patients, non-Hispanic black patients, and those in the lowest SES quartile (p < 0.05). In the adjusted survival model, only advanced disease and malignant behavior were predictive of mortality. CONCLUSIONS Racial/ethnic disparities are associated with advanced-stage disease presentation for children with CNS solid tumors. Disease stage at presentation and tumor behavior are the most important predictors of survival.
Related Concept Videos
Treatment Resistant Cancers
Treatment Resistent Cancers
Pharmacokinetics in Pediatric Patients: Drug Distribution
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Tumor Progression

